# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-004571
Filing Date
2025-04-14
Accepted
2025-04-14 16:15:33
Documents
47
Period of Report
2025-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 666143
2 |  | ex31-1.htm | EX-31.1 | 9790
3 |  | ex31-2.htm | EX-31.2 | 9922
4 |  | ex32-1.htm | EX-32.1 | 5327
5 |  | ex32-2.htm | EX-32.2 | 5070
| Complete submission text file | 0001641172-25-004571.txt |  | 3884115

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | bmra-20250228.xsd | EX-101.SCH | 23442
7 | XBRL CALCULATION FILE | bmra-20250228_cal.xml | EX-101.CAL | 44878
8 | XBRL DEFINITION FILE | bmra-20250228_def.xml | EX-101.DEF | 102919
9 | XBRL LABEL FILE | bmra-20250228_lab.xml | EX-101.LAB | 252336
10 | XBRL PRESENTATION FILE | bmra-20250228_pre.xml | EX-101.PRE | 188735
49 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 551216

Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 25836205
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)